Cytomegalovirus Infections
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Valganciclovir to Reduce T Cell Activation in HIV Infection [Phase 4]
A Phase 4 trial evaluating valganciclovir to reduce T cell activation in HIV infection has completed with results posted in 2013.
-
CLINICAL_TRIALS research · 2013-08-22Clinical Trial Update: Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients [Phase 4]
A Phase 4 clinical trial investigates early use of Everolimus to manage cytomegalovirus infections in renal transplant recipients; the study…
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant [Phase 3]
Phase 3 trial comparing preemptive oral valganciclovir to intravenous ganciclovir for cytomegalovirus infections after bone marrow or periph…
-
FDA approval · 2012-06-27FDA Approved: CIDOFOVIR — Original Application (Mylan Institutional LLC)
FDA approved the original application for cidofovir anhydrous (CIDOFOVIR) from Mylan Institutional LLC, indicating a generic version of cido…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. [Phase 3]
A Phase 3 trial tested whether valganciclovir prevents cytomegalovirus infections in bone marrow/stem cell transplant recipients. The study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Neonatal CMV-Ganciclovir Follow-up Study
A completed follow-up clinical trial evaluating ganciclovir for neonatal cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients [Phase 3]
Phase 3 trial evaluating artesunate for preemptive treatment of cytomegalovirus infection in stem cell transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
This completed clinical trial evaluated factors associated with cytomegalovirus disease in solid organ transplant recipients.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus [Phase 3]
A Phase 3 trial evaluating valganciclovir for recurrent cytomegalovirus-associated inflammatory bowel disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections [Phase 2]
A Phase 2 clinical trial evaluated the effects of hormone therapy on immune function in postmenopausal women with chronic infections, and th…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Immune Response to Cytomegalovirus
The document reports the completion/update of an NHLBI-sponsored clinical trial studying immune responses to cytomegalovirus infections.
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial [NA]
Open randomized trial assessing the impact of intensive education and coaching on adherence to oral ganciclovir for CMV prophylaxis.